Stephanie Graff, MD, concludes the discussion with thoughts on endocrine therapies in development for patients with ER+/HER2- metastatic breast cancer.
Stephanie L. Graff, MD
Advertisement
Articles by Stephanie L. Graff, MD
An expert on breast cancer reviews currently available tests for ESR1 mutations and provides clinical insights on best practices for testing.
Stephanie L. Graff, MD, provides an overview of ESR1 mutations in ER+/HER2- metastatic breast cancer, highlighting their prevalence, clinical implications, and challenges.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Prescription Access Crisis: 40% of GLP-1 RA Rx Are Unfilled
2
FDA Expands Upadacitinib Label for Treating Inflammatory Bowel Disease
3
Experts, Patients Highlight Barriers to Arthritis Care Amid World Arthritis Day Observance
4
Efficacy and Safety of Dupilumab in AD Across Diverse Pediatric Populations: A Q&A With Elaine Siegfried, MD
5
